Spero Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Spero Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Spero Therapeutics Inc
Rating: 1.50116675
Author: Trendlyne DVM scores

about

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, teb...

2.21 -0.01 (-0.45%)

31.37% Fall from 52W High

273.2K

XNAS Volume

XNAS 26 Feb, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

16.7 / 100

Technically Neutral

43.4 / 100

1Yr Price target upside is 81%

1 analysts

Spero Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Spero Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, teb...

31.37% Fall from 52W High

SWOT Analysis

Spero Therapeutics Inc Live Price Chart